|
Abnormal HIF signaling in Down syndrome-related pulmonary hypertension |
1R21HL165364-01 |
|
NHLBI |
2022 |
|
Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs |
1R21HL165406-01 |
|
NHLBI |
2022 |
|
type I interferon regulates angiogenesis in Down Syndrome |
1R21HL165411-01 |
|
NHLBI |
2022 |
|
Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization. |
1R43HL160311-01A1 |
|
NHLBI |
2022 |
|
A universal ambient air-oxygen blender to treat respiratory distress in newborns |
1R43HL162270-01 |
|
NHLBI |
2022 |
|
Home sleep apnea testing compared to in-lab polysomnography for the evaluation of obstructive sleep apnea in children |
1R61HL162839-01 |
|
NHLBI |
2022 |
|
Treatment of Obstructive Sleep Apnea with Personalized Surgery in Children with Down Syndrome (TOPS-DS) |
1R61HL165345-01 |
|
NHLBI |
2022 |
|
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea |
1R61HL165366-01 |
|
NHLBI |
2022 |
|
Phenotypes and mechanisms of pulmonary hypertension-driven cognitive impairment and Alzheimers disease |
3R01HL154754-03S1 |
|
NHLBI |
2022 |
|
Type I IFN signaling during lung development in Down Syndrome-Multiome sequencing of human fetal and pediatric trisomy 21 lungs |
3R01HL155104-01A1S1 |
|
NHLBI |
2022 |